Delivery Order SPE2DB20D2014-SPE2DB24FB88P

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S. The $8,953.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a $10,262.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count packages. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,312.55 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of August 13, 2024 and does not utilize a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,868.36 firm fixed-price delivery order is for the supply of 90 tablets of the medication Valsartan-HCTZ 160-12.5 mg. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 2025. This single-award IDC enables...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles. The $4,985.07 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,018.59 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,611.65, is for the delivery of valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,615.47, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of June 5, 2024 and is a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,198.16, is a Firm Fixed Price Delivery Order for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,808.90 firm fixed-price delivery order is for the supply of 4,557,842,714 valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB88P
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The $13,776.14 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/16/25, 11:46 AM